JiffyStent Announced as Recipients of MTAA's MedTech Market Growth Program Grant
|
Awarded Winners at AusMedtech 2024's Early Stage Innovation Forum
|
JiffyStent Announced as Recipients of MTAA's MedTech Market Growth Program Grant | Awarded Winners at AusMedtech 2024's Early Stage Innovation Forum |
JiffyStent
Revolutionising the management of acute renal colic and kidney stones
A revolutionary medical device that enables the immediate insertion of a ureteric stent in the Emergency Department using clinician’s smartphone as the screen.
The JiffyStent® avoids the need for hospital admission and a trip to the operating theatre and associated general anaesthetic, thereby saving considerable time, resources, and costs.
Supported By
The Challenge
10% of the population will experience excruciating kidney stone pain at some point in their lives
Every year, 0.2% of the population has an episode of kidney stone pain requiring a trip to the Emergency Department. And every year, 600,000 stents are inserted to alleviate kidney stone pain.
Current management of the excruciating pain caused by obstructive kidney stones is unnecessarily costly in terms of prolonged pain, money, and time.
It entails a long and complicated regime of strong opioid pain relief, fasting, waiting for Operating Theatre availability, and the administration of general anaesthetic, all for a procedure that should otherwise take under five minutes.
JiffyStent will revolutionise the management of this condition, entering the market with a simple, safe, and cost-effective solution that will reap significant benefits for patient wellbeing, hospital workflow, and health economics.
Patients receive on-the-spot relief from their pain and can resume normal life quicker, while the pressure on already overburdened hospital systems is significantly reduced.
How it Works
The Team
Headquartered in Melbourne, Australia, JiffyStent comprises a small leadership team and dedicated group of advisors. Our team of experts is committed to helping bring to life a cost-effective medical device that transforms the global care pathway for patients with kidney stone pain.
The advisory group brings a wealth of experience and expertise across fields such as med-tech, urology, manufacturing, medical devices, commercialisation, tooling and manufacture, funding, regulation, clinical trials, hospital systems, and procurement.
How it Works
-
Co-Founder & Chief Executive Officer
Joseph is a urologist, surgeon scientist and clinical entrepreneur with a PhD and Associate Professorship with the University of Melbourne. He has over 15 years experience in the management of acute renal colic and kidneys stones.
Joseph has been the PI and SI on multiple phase 1, 2 and 3 national and international clinical trials. He founded the “Talking Urology” podcast in 2016, one of the top ranking global urology podcasts.
-
Co-Founder & Chief Engineer
Donald (Don) boasts six decades of engineering experience, including 20+ years dedicated to medical research and the development of medical devices.
In 2006, Don was named among the Top 100 Australia’s most influential engineers.
-
Chief Operations Officer
Cyril has held senior management and executive roles in the healthcare and not-for-profit sectors, overseeing large-scale global projects.
Cyril is the former global director of clinical services at the Movember Foundation and chief – support services at Ovarian Cancer Australia.
Implementation Partners
News & Resources
Latest Updates
Contact Us
Got Questions? Reach Out to Us.
Get in touch with us via the contact form, or email us at support@jiffystent.com
Learn the effects of lengthy wait times on kidney stone patients and the need for a care pathway that doesn’t rely on operating room (OR) slots to provide immediate pain relief.